Summary
This computational chemistry study screened isatin-linked chalcone analogues for potential anti-tuberculosis activity by optimising their binding to NADH-dependent enoyl-ACP reductase (InhA). Four compounds exhibited superior docking scores (−10.2 to −10.5) compared to isoniazid's −10.3, suggesting promising in silico candidates. The authors recommend further in vitro and in vivo testing of these compounds to validate their therapeutic potential.
UK applicability
The findings have indirect relevance to UK tuberculosis research and pharmaceutical development pipelines. Computational drug screening studies such as this contribute to the global evidence base for novel antimicrobial agents, though clinical applicability requires translational research beyond the scope of this in silico work.
Key measures
Molecular docking scores (binding affinity); comparison against isoniazid standard; compound ranking by docking score
Outcomes reported
The study evaluated molecular docking scores of synthesised chalcone isatin compounds against the tuberculosis target protein InhA (4QXM), comparing binding affinity to the standard drug isoniazid. Four compounds (6, 7, 8, 9) demonstrated docking scores of −10.2 to −10.5, exceeding isoniazid's score of −10.3 in this domain.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.